We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Grace Opens GMP Release QC Lab at Oregon Facility

Read time: Less than a minute

W. R. Grace & Co. has announced the opening of a Good Manufacturing Practice (GMP) release Quality Control (QC) lab at its fine chemicals manufacturing facility located in Albany, Oregon, expanding support for GMP manufacturing and release for the pharmaceutical and dietary-related industries. The new lab’s capabilities will enable the site to validate analytical methods and perform GMP release of starting materials and advanced intermediates.

The lab already has passed customer inspections and completed method validation and GMP release of commercial intermediates for major pharmaceutical companies. The analytical equipment in the lab includes HPLC, UPLC, GC-MS, and GC-MS with head space, along with other common analytical equipment.

“Grace continues to invest and expand our capabilities in custom manufacturing of regulatory materials,” said Brett Reynolds, Global Business Director for Fine Chemicals. “This higher level GMP manufacturing expands our portfolio of products and services to the pharmaceutical and related industries.”

Grace acquired the Albany facility from Synthetech, Inc. in 2010. The Albany site’s operations team has more than 30 years of custom manufacturing experience in multi-step organic, organometallic, and chiral chemistry, and integrated kilos-to-tons GMP production.